Trexquant Investment’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,956
Closed -$349K 1846
2022
Q4
$349K Buy
+2,956
New +$349K 0.01% 1051
2022
Q3
Sell
-660
Closed -$59K 1907
2022
Q2
$59K Buy
+660
New +$59K ﹤0.01% 1462
2022
Q1
Sell
-1,548
Closed -$461K 1802
2021
Q4
$461K Buy
+1,548
New +$461K 0.03% 688
2021
Q2
Sell
-488
Closed -$263K 1570
2021
Q1
$263K Buy
+488
New +$263K 0.02% 818